Overexpressed poly(ADP-ribose) polymerase delays the release of rat cells from p53-mediated G1 checkpoint

Journal of Cellular Biochemistry

Volumn 80, Issue 1, 2001, Pages 85-103

  Wȩsierska Ga̧dek, Józefa ^a   Schmid, Gerald ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cell cycle; G1 arrest; Mdm 2; Nuclear p53; Overexpressed PARP; Stabilization of wt p53; Ts p53

Indexed keywords

DNA; LEPTOMYCIN B; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN P53;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; DNA CONTENT; FLOW CYTOMETRY; GENE OVEREXPRESSION; IMMUNOBLOTTING; NONHUMAN; PLASMID; PRIORITY JOURNAL; RAT; TUMOR SUPPRESSOR GENE;

ANIMALIA;

EID: 0033759112     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-4644(20010101)80:1<85::AID-JCB80>3.0.CO;2-1     Document Type: Article

References (68)

1. Defective induction but normal activation and function of p53 in mouse cells lacking poly-ADP-ribose polymerase
2. Specific inhibitors of poly(ADP-ribose) synthetase and mono(ADP-ribosyl)transferase
3. Poly(ADP-ribose) in the cellular response to DNA damage
4. Functional overexpression of human poly(ADP-ribose) polymerase in transfected rat tumor cells
5. Cell cycle regulation of an endogenous human poly(ADP-ribose) polymerase cDNA introduced into murine cells
6. mdm2-P2 transcript levels predict the functional activity of the p53 tumor suppressor in primary leukemic cells
7. Differences in the regulation by poly(ADP-ribose) of repair of DNA damage from alkylating agents and ultraviolet light according to cell type
8. Tumour suppressors, kinases and clamps: How p53 regulates the cell cycle in response to DNA damage
9. Poly(ADP-ribosly)ation reactions in the regulation of nuclear functions
10. The tumor suppressor p53
11. Definition of a consensus binding site for p53
12. WAF-1, a potential mediator of p53 tumour suppression
13. Overproduction of p53 antigen makes established cells highly tumorigenic
14. Wild-type p53 can inhibit oncogene-mediated focus formation
15. The p53 protooncogene can act as a suppressor of transformation
16. Cdk-interacting protein i directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase δ holoenzyme
17. Nuclear export is required for degradation of endogenous p53 by MDM2 and human papilloma virus E6
18. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents
19. A transcriptionally active DNA-binding site for human p53 protein complex
20. Protein synthesis required to anchor a mutant p53 protein which is temperature-sensitive for nuclear transport
21. Induction of the WAF1/CIP1 protein and apoptosis in human T-cell leukemia virus type I - Transformed lymphocytes after treatment with Adriamycin by using a p53-independent pathway
22. 1 cyclin-dependent kinases
23. Mdm2 promotes the rapid degradation of p53
24. Protease activation and cleavage of poly(ADP-ribose) polymerase: An integral part of apoptosis in response to photodynamic treatment
25. Participation of p53 protein in the cellular response to DNA damage
26. Induction of endonucleolytic DNA cleavage in human myelogenous leukemia cells by etoposide, camptothecin and other cytotoxic anticancer drugs: A cautionary note
27. The 193-kD vault protein, VPARP, is a novel poly(ADP-ribose) polymerase
28. Characterization of distinct consecutive phases in non-genotixic p53-induced apoptosis of Ewing tumor cells and the rate-limiting role of caspase 8
29. Regulation of p53 stability by Mdm2
30. Characterization of the execution phase of apoptosis in vitro using extracts from condemned-phase cells
31. 1 phase
32. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells
33. XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage
34. Poly(ADP-ribose) polymerase gene disruption conferred mice resistant to streptozotocin-induced diabetes
35. Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells
36. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
37. Nuclear architecture and ultrastructural distribution of poly(ADP-ribosyl) transferase, a multifunctional enzyme
38. Ribosomal gene transcription is organized in foci within nucleolar components
39. Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis
40. The Ink4a tumor suppressor , p19(Arf) interacts with MDM2 and neutralizes MDM2's inhibition of p53
41. Enhanced poly(adenosine diphosphate ribose) polymerase activity and gene expression in Ewing's sarcoma cells
42. Cancer-associated mutations at the INK4a locus cancel cell cycle arrest by p16(INK4a) but not but by the alternative reading frame protein p19(ARF)
43. Growth regulation of a cellular turnout antigen, p53 in nontransformed cells
44. Mechanisms of DNA excision repair
45. Poly(ADP-ribosyl)ation of p53 during apoptosis in human osteosarcoma cells
46. Poly(ADP-ribose) Polymerase inhibitors preserve nicotinamide adenine dinucleotide and adenosine 5'-triphosphate pools in DNA-damaged cells: Mechanism of stimulation of unscheduled DNA synthesis
47. Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen
48. Tankyrase, a poly(ADP-ribose) polymerase at human telomeres
49. A leucine-rich nuclear export signal in the p53 tetramerization domain: Regulation of subcellular localization and p53 activity by NES masking
50. p53 Transcriptional activation mediated by coactivators TAF(II)40 and TAF(II)60
51. DNA repair defect in poly(ADP-ribose) polymerase-deficient cell lines
52. The p53 tumor suppressor protein, a modulator of cell proliferation
53. Overexpresion of human poly(ADP-ribose)polymerase in transfected hamster cells leads to increased poly(ADP-ribosyl)ation and cellular sensitization to γ irradiation
54. ATM-dependent telomer loss in aging human diploid fibroblasts and DNA damage lead to the posttranslational modification of p53 protein involving poly(ADP-ribose) polymerase
55. Biological and clinical importance of the p53 tumor suppressor gene
56. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis
57. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA
58. Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease
59. PARP is important for genomic stability but dispensable in apoptosis
60. Autoantibodies from patients with primary biliary cirrhosis preferentially reacts with the amino-terminal domain of nuclear pore complex glycoprotein gp210
61. ADP-ribosylation of p53 tumor suppressor protein: Mutant but not wild-type p53 is modified
62. ADP-ribosylation of wild-type p53 in vitro: Binding of p53 protein to specific p53 consensus sequence prevents its modification
63. Cleavage of poly(ADP-ribose) transferase during p53-independent apotposis in rat liver after treatment with N-nitrosomorpholine and cyproterone acetate
64. Reduced stability of regularly spliced but not alternatively spliced p53 protein in PARP-deficient mouse fibroblasts
65. Differential susceptibility of normal and PARP knock-out mouse fibroblasts to proteasome inhibitors
66. Involvement of NAD-poly(ADP-ribose) metabolism in p53 regulation and its consequences
67. Leptomycin B is an inhibitor of nuclear export: Inhibition of nucleocytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA
68. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6